By Admin at 30 Jan 2017

Two new studies have shed light and reveal methods that might exploit points of cancer weakness to stop its spread and resistance.

By Admin at 25 Jan 2017

Women with advanced ovarian cancer may have a new option for treatment. The U.S. Food and Drug Administration (FDA) granted accelerated approval to Rubraca (rucaparib), a poly ADP-ribose polymerase (PARP) inhibitor.

By Admin at 12 Jan 2017

A Gateway-funded clinical trial is making big news for breakthrough success in brain cancer. For the first time, researchers have successfully used a form of immunotherapy, which harnesses a patient’s own immune system to fight cancer, to treat an aggressive type of brain tumor called glioblastoma.